Vertex Pharmaceuticals Incorporated
Patents, Design & Utilities
Last updated:
List of all Vertex Pharmaceuticals Incorporated patents 160 in total
| Status | Patent |
|---|---|
Grant | Utility: Modulators of ATP-binding cassette transporters Filling date: 12 Sep 2025 Issue date: 13 Apr 2021 |
Application | Utility: CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS Filling date: 12 Sep 2025 Issue date: 1 Apr 2021 |
Grant | Utility: Substituted pyrazines as ATR kinase inhibitors Filling date: 12 Sep 2025 Issue date: 30 Mar 2021 |
Application | Utility: DNA-PK INHIBITORS Filling date: 12 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS Filling date: 12 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: DNA-PK INHIBITORS Filling date: 12 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Filling date: 12 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: A METHOD OF TREATING PAIN Filling date: 12 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: MODULATOR OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: PROCESS OF MAKING CFTR MODULATORS Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: CRYSTALLINE FORMS OF CFTR MODULATORS Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: CRISPR/CAS ALL-IN-TWO VECTOR SYSTEMS FOR TREATMENT OF DMD Filling date: 12 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: GCN2 INHIBITORS AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 11 Feb 2021 |
Grant | Utility: 2,7-dibromospiro[fluorene-9,4'-piperidine] compounds Filling date: 12 Sep 2025 Issue date: 9 Feb 2021 |
Application | Utility: COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Filling date: 12 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR Filling date: 12 Sep 2025 Issue date: 4 Feb 2021 |
Grant | Utility: Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-- fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxa- mide Filling date: 12 Sep 2025 Issue date: 2 Feb 2021 |
Application | Utility: PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF Filling date: 12 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS Filling date: 12 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: IMPLANTATION DEVICES, SYSTEM, AND METHODS Filling date: 12 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: FORMULATIONS OF AZAINDOLE COMPOUNDS Filling date: 12 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES Filling date: 12 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: CRYSTALLINE FORMS OF MODULATORS OF CFTR Filling date: 12 Sep 2025 Issue date: 14 Jan 2021 |
Grant | Utility: Inhibitors of influenza viruses replication Filling date: 12 Sep 2025 Issue date: 29 Dec 2020 |
Application | Utility: TREATING CANCER WITH ATR INHIBITORS Filling date: 12 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: CRYSTALLINE FORMS AND COMPOSITIONS OF CFTR MODULATORS Filling date: 12 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: CRISPR-CAS9 MODIFIED CD34+ HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: PRODRUGS OF PYRIDONE AMIDES USEFUL AS MODULATORS OF SODIUM CHANNELS Filling date: 12 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: SOLID FORMS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-- METHYLPYRIDIN-2-YL) BENZOIC ACID Filling date: 12 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: INHIBITORS OF APOL1 AND METHODS OF USING SAME Filling date: 12 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: PROCESSES FOR PREPARING PYRROLIDINE COMPOUNDS Filling date: 12 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: MODULATORS OF ALPHA-1 ANTITRYPSIN Filling date: 12 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: QUINOXALINONE COMPOUNDS, COMPOSITIONS, METHODS, AND KITS FOR INCREASING GENOME EDITING EFFICIENCY Filling date: 12 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE- -3-CARBOXAMIDE Filling date: 12 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: DNA-PK INHIBITORS Filling date: 12 Sep 2025 Issue date: 12 Nov 2020 |
Grant | Utility: Processes for preparing ATR inhibitors Filling date: 12 Sep 2025 Issue date: 3 Nov 2020 |
Application | Utility: CRYSTALLINE FORMS OF C21H22Cl2N4O2 Filling date: 12 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES Filling date: 12 Sep 2025 Issue date: 29 Oct 2020 |
Grant | Utility: Antiproliferation compounds and uses thereof Filling date: 12 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Compounds useful as inhibitors of ATR kinase Filling date: 12 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Treating cancer with ATR inhibitors Filling date: 12 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto Filling date: 12 Sep 2025 Issue date: 20 Oct 2020 |
Grant | Utility: Compounds useful as inhibitors of ATR kinase Filling date: 12 Sep 2025 Issue date: 13 Oct 2020 |
Grant | Utility: Influenza A virus variants Filling date: 12 Sep 2025 Issue date: 13 Oct 2020 |
Grant | Utility: Influenza A virus variants Filling date: 12 Sep 2025 Issue date: 13 Oct 2020 |
Grant | Utility: GCN2 inhibitors and uses thereof Filling date: 12 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator Filling date: 12 Sep 2025 Issue date: 6 Oct 2020 |
Showing 50 to 100 of 160 patents.